Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Richard Doubleday currently holds 6,748 shares of DEXCOM INC (DXCM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Richard Doubleday has been a net seller of DXCM stock. They have purchased $0 and sold $37.8M worth of shares.
Richard Doubleday's most recent insider trade was on Mar 23, 2021, when they sold 268 shares at $361.37 per share.
Richard Doubleday serves as Executive at DEXCOM INC (DXCM). They have executed 234 insider transactions totaling $37.8M over their tenure at the company.
Richard Doubleday holds the position of Executive at DEXCOM INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 15 years and currently hold a stake valued at $0.
Richard Doubleday has shown a selling trading pattern, with $0 in total purchases and $37.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Richard Doubleday was on Jan 4, 2021, when they sold $4.0M worth of DXCM shares. This transaction involved 10,970 shares at $366.07 per share.
Richard Doubleday currently owns 6,748 shares of DEXCOM INC (DXCM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Richard Doubleday's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Richard Doubleday has 234 Form 4 filings on record as an insider at DEXCOM INC.
Set alerts for Richard Doubleday and 40,000+ other insiders.